ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,982Medicare Part D Prescriptions Filled, Including Refills

Rank: 58 out of 1942

$376K Total Retail Price of All Prescriptions

Rank: 270 out of 1942

370 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 370 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

18% of this provider’s 370 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

0% of this provider’s 10,213 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$34 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
LEVOTHYROXINE SODIUM 487 468 1 3
SUCRALFATE 473 456 10 2 149
LISINOPRIL 449 444 3 2
OMEPRAZOLE 425 414 4 4
FUROSEMIDE 373 364 5 5
HYDROCODONE-ACETAMINOPHEN 351 345 S3 6 12
POTASSIUM CHLORIDE 328 302 7 17
FAMOTIDINE 307 248 8 87
AMLODIPINE BESYLATE 295 282 9 6
SERTRALINE HCL 293 291 10 20
SIMVASTATIN 276 264 11 1
METOPROLOL SUCCINATE 246 245 12 13
MIRTAZAPINE 231 227 13 38
DONEPEZIL HCL 222 221 14 30
METOPROLOL TARTRATE 212 206 15 9
GABAPENTIN 192 158 16 16
JANTOVEN 188 139 17 33
ATENOLOL 157 157 18 7
CITALOPRAM HBR 152 152 19 15
ISOSORBIDE MONONITRATE ER 143 143 20 42
POLYETHYLENE GLYCOL 3350 143 135 20 28
WARFARIN SODIUM 138 123 22 11
DIGOXIN 137 137 23 40
CARBIDOPA-LEVODOPA 136 136 24 64
LOSARTAN POTASSIUM 118 118 25 18
DIOVAN 112 102 26 44
IPRATROPIUM-ALBUTEROL 111 73 27 134
PRAVASTATIN SODIUM 91 91 28 23
RISPERIDONE 89 77 29 68
PREDNISONE 82 66 30 27
QUETIAPINE FUMARATE 80 58 31 61
TRAZODONE HCL 76 73 32 24
NAMENDA 75 75 33 51
FENTANYL 74 74 S2 34 47
METFORMIN HCL 74 68 34 10
CARVEDILOL 68 68 36 39
ATORVASTATIN CALCIUM 66 66 37 14
OXYCODONE HCL 64 44 S2 38 52
HYDROCHLOROTHIAZIDE 64 64 38 8
LATANOPROST 63 63 40 178
OXYCONTIN 61 48 S2 41 84
TAMSULOSIN HCL 61 60 41 29
INSULIN SYRINGE 59 48 43 142
CILOSTAZOL 57 57 44 270
ALLOPURINOL 54 45 45 26
BUDESONIDE 53 53 46 277
LANTUS 53 34 46 49
PAROXETINE HCL 51 34 48 50
DIVALPROEX SODIUM 50 50 49 91
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 21, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.